Dados B3 › BPHA3 × HAPV3
BPHA3 × HAPV3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BPHA3 | HAPV3 | year |
|---|---|---|---|
| ROE | -149.5% | -0.3% | no year where both have it (2016 × 2025) |
| ROIC | -348.5%! | 1.8%! | no year where both have it (2017 × 2025) |
| ROA | 966.4%! | 21.0% | 2018 |
| Gross margin | 98.3%! | 39.8% | 2018 |
| EBIT margin | -302.4%! | 19.0% | 2018 |
| Net margin | 10,996.5%! | 17.2% | 2018 |
| Net debt/EBITDA | 19.79x | 1.66x | no year where both have it (2013 × 2025) |
| Current ratio | 0.06x! | 1.29x | 2018 |
| Revenue growth (1y) | -17.5%! | 18.9% | 2018 |
| Revenue growth (5y CAGR) | -68.9%! | 29.8% | no year where both have it (2018 × 2025) |
| Piotroski F-Score | 5/9! | 3/9! | 2018 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BPHA3 | HAPV3 | year |
|---|---|---|---|
| P/E | 0.15x | -27.50x | 2018 × 2025 |
| P/B | — | 0.08x | 2018 × 2025 |
| EV/EBITDA | — | 2.95x | 2018 × 2025 |
| FCF yield | -55.2% | 26.2% | 2018 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 16:53 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 16:53 UTC. If this does not match /saude, you are reading a cached copy.